Weitz & Luxenberg has achieved a $13.34 million judgment on a behalf of a victim who was viciously attacked at a bar in Queens, New…Read More
HarrisMartin’s MDL Conference Features W&L Attorney As Invited FacultyJul. 7, 2015
W&L attorney David L. Rosenband has been invited as a faculty member for the upcoming HarrisMartin MDL Conference: Zofran, Bard IVC and Zimmer Persona Knee Litigation.
Rosenband serves as an associate attorney on our Defective Drugs and Devices team. An experienced litigator, he has been involved in a number of significant medical device and pharmaceutical cases, including the Zimmer NexGen Knee litigation. Rosenband previously served as co-plaintiff liaison counsel in the New York Bextra and Celebrex product liability litigation. He was also part of the trial team for a former Accutane user securing a $9-million verdict for that client.
At this conference, he will be speaking on the recently recalled Zimmer Persona Trabecular Metal™ Tibial Plate. He will be joined by colleague, Christopher A. Seeger, from Seeger Weiss LLP, in discussing the device. The presentation will review why it has been recalled, including a summary of the device, and how to best present the case legally to get the most compensation possible for clients.
Other distinguished attorneys are also participating in the seminar. They will present litigation updates on DePuy Pinnacle, Zimmer NexGen Knee, contaminated endoscopes, testosterone, Risperdal and Actos.
The conference will be held on July 29, 2015 at the Hotel Nikko San Francisco in San Francisco, California. Harris Publishing is offering continuing legal education (CLE) credits for the conference, where possible.
Get more information about the Zofran, Bard IVC and Zimmer Persona Knee Litigation Conference.
Our firm, W&L is also pursuing litigations in many of these drug and medical device areas, along with others including SGLT2 inhibitors, Maquet’s TigerPaw System II and the Zimmer ProxiLock Hip Prothestis Stem.
You are invited to request a free case review by filling out our form, engaging in an online chat or calling us at (800) 476-6070.